Wai Chin

Wai Chin is currently the Senior Director of Biostatistics at Pfizer, a position they have held since 2023. Prior to this, they served as a Director of Biostatistics at Biogen from 2020 to 2022 and held various leadership roles at bluebird bio, EMD Serono, Inc., and Genzyme Sanofi, accumulating extensive experience in the field. Wai Chin also briefly worked as a Senior Director of Biostatistics at Global Blood Therapeutics in 2022. They are pursuing a Doctor of Philosophy (Ph.D.) at the University of Maryland College Park.